Dr. Jintanat Ananworanich serves as the Associate Director for Therapeutics Research at the U.S. Military HIV Research Program (MHRP). In this role, Dr. Ananworanich oversees adult HIV therapeutic trials as part of the NIH-funded MHRP Clinical Trials Unit under the AIDS Clinical Trials Group. She has more than 200 publications and is currently the principal investigator on the MHRP/NIAID-funded acute HIV infection study, RV254. In addition to membership on the steering committee of the Pediatric European Network for Treatment of AIDS and the steering Committee of the IAS Towards an HIV Cure Initiative, Dr. Jintanat is a member of the ACTG and the IMPAACT HIV Cure committees and co-chairs the acute HIV infection working group of the ACTG and the clinical research working group of the Forum Cure Project. Dr. Ananworanich received her medical degree from Prince of Songkhla Medical School in Thailand. Following medical school she studied HIV dendritic cells as a volunteer researcher in the lab of Dr. Anthony S. Fauci at NIAID. Dr. Ananworanich went on to complete a pediatric residency at the University of Chicago and fellowships in allergy and immunology clinical and laboratory immunology at Baylor College of Medicine in Houston. In addition, Dr. Ananworanich received her Ph.D. in Medicine from the University of Amsterdam with Professor Joep Lange.
https://www.i4cacure.org/wp-content/uploads/2018/01/Jintinant-Ana..png 874 896 awp-admin /wp-content/uploads/2017/11/white-image-page-001-180x180.jpg awp-admin2018-01-23 21:57:012022-08-03 19:47:54Jintanat Ananworanich, M.D., Ph.D.